Ignite Creation Date:
2024-05-11 @ 8:29 AM
Last Modification Date:
2024-07-22 @ 10:50 PM
Study NCT ID:
NCT06399965
Status:
WITHDRAWN
Last Update Posted:
2024-07-05
First Post:
2024-04-22
Brief Title:
Perioperative Use of Atosiban for Ultrasound-indicated Cerclage to Reduce Spontaneous Preterm BirthsPTB
Sponsor:
First Affiliated Hospital of Chongqing Medical University
Organization:
First Affiliated Hospital of Chongqing Medical University
Study Overview
Official Title:
Perioperative Use of Atosiban for Ultrasound-indicated Cerclage to Reduce Spontaneous Preterm Birth A Randomized Double-blind Clinical Trial
Status:
WITHDRAWN
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Due to ethical concerns data from First Affiliated Hospital of CQMU cannot be included The Investigators request to withdraw trial NCT06399965 and re-register with Chongqing Maternal and Child Health Hospital as the primary site
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
After ultrasound-indicated cerclage some pregnant women still experience sPTB and there is controversy regarding the use of tocolytic agents during the perioperative period to reduce the incidence of sPTB In this study the investigators employed a randomized double-blind method to investigate whether the use of atosiban during the perioperative period can reduce the incidence of sPTB before 34 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None